OC-043 Long term efficacy and safety of ustekinumab for crohn’s disease: results from im-uniti long-term extension through 2 years
WJ Sandborn, P Rutgeerts, C Gasink, D Jacobstein, L Gao, J Johanns, B Sands, S Hanauer, S Targan, S Ghosh, WJS de Villiers, JF Colombel, BG Feagan
Gut Jul 2017, 66 (Suppl 2) A22; DOI: 10.1136/gutjnl-2017-314472.43